by PierianDx, on February 7, 2019
At PierianDx, we are well-versed in helping healthcare organizations implement clinical next generation sequencing (NGS) testing programs. But beyond implementation of genomic testing programs at individual institutions, what must happen …
Read Storyby PierianDx, on January 4, 2019
Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis ST. LOUIS, MO - JANUARY 4, …
Read Storyby PierianDx, on October 24, 2018
Precision medicine is the ability to use genomic information to optimize diagnosis and treatment and provide better outcomes for patients. “We Know Precision Medicine” is a series of blog posts …
Read Storyby PierianDx, on September 28, 2018
Join us October 31- November 3 at the Association for Molecular Pathology (AMP) annual meeting in San Antonio, Texas. Visit us any day of the conference in Booth 800. Also, …
Read Storyby PierianDx, on September 13, 2018
Precision medicine is the ability to use genomic information to optimize diagnosis and treatment and provide better outcomes for patients. We Know Precision Medicine is a series of blog posts …
Read Storyby Michael L. Sanderson, on September 4, 2018
In many healthcare settings the important role of pathology is underestimated and misunderstood. Likely, we can thank TV crime shows for the public perception that pathologists only perform autopsies and complicated …
Read Storyby PierianDx, on August 29, 2018
Are you considering offering clinical NGS testing or looking for an economical approach to building your program? If so, then you know that any eagerness to implement clinical NGS can …
Read Storyby PierianDx, on August 24, 2018
We Know Precision Medicine is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In …
Read Storyby PierianDx, on August 14, 2018
Recently we hosted a webinar in which Medical Director, Shalini Verma, and VP Product, Andy Bredemeyer, reviewed and applied the Association for Molecular Pathology (AMP) joint consensus guidelines for the …
Read Storyby Lisa Owen, on July 26, 2018
"We Know Precision Medicine" is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In …
Read Storyby Lisa Owen, on July 13, 2018
Preparing for our upcoming webinar -- A Practice-based Guide for Interpretation and Reporting of Sequence Variants in Cancer--caused us to think about the evolution of next generation sequencing (NGS) into …
Read Storyby PierianDx, on June 27, 2018
"We Know Precision Medicine" is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In …
Read Story
77 Maryland Plaza
St. Louis, Missouri 63108
314-628-0035